India, Aug. 28 -- Today's top gainers in the biotech and healthcare space include Aethlon Medical, following narrower quarterly losses and progress in its Hemopurifier oncology study; Quoin Pharmaceuticals, on positive QRX003 data and a $50 million financing; Dogwood Therapeutics, as its Halneuron Phase 2b trial advances toward a fall readout; and Freenome, after receiving FDA Breakthrough Device Designation for its lung cancer screening test.
Read on...
AEMD Shares Jump As Q1 Loss Narrows 12%, Hemopurifier Program Advances
Aethlon Medical, Inc. (AEMD) shares jumped after the company reported a 12% year-over-year narrowing in its Q1 loss to $1.55 million, compared with $1.76 million a year earlier.
Operating expenses declined to $1.58 m...